• Journal of Oriental Neuropsychiatry
• /
• v.29 no.3
• /
• pp.145-163
• /
• 2018

Objectives: The study was designed to provide clinical evidence of homogeneity in analysis of the herbal medicine, Guipi decoction in treating insomnia, using a t-test of randomized controlled trials (RCTs). Methods: This study included RCTs that verified homogeneity of Guipi decoction in treating insomnia. Literature studies of CNKI (Chinese National Knowledge Infrastructure Database) were performed. The basic components group was made to the Guipi decoction of the Yixuerumen?s text. The excluded group was created with the number of herbs excluded from the basic components group. T-test performed that the effective rate in the basic components group and excluded groups. Results: The basic components of Guipi decoction contain Atractylodis Rhizoma Alba, Poria Sclerotium (Poria Sclerotium Cum Pini Radix), Polygalae Radix, Astragali Radix, Zizyphi Semen, Angelicae Gigantis Radix, Aucklandiae Radix, Glycyrrhiza uralensis Fischer, Ginseng Radix (Codonopsis Pilosulae Radix), Longanae Arillus. Herbs excluded from the basic components group were Longanae Arillus, Ginseng Radix (Codonopsis Pilosulae Radix), Glycyrrhiza uralensis Fischer and herbs added to the basic components group were Polygonum multiflorum Thunberg, Schisandrae Fructus, Salviae Militiorrhizae Radix, Paeoniae Radix Alba (in order from the most used to the least). T-test revealed the effective rate in the basic components group was not statistically significant compared to the excluded groups (p=0.161/p=0.162/p=0.103). Conclusions: Effectiveness in treatment of basic components of Guipi decoction and excluded groups were revealed to be homogeneous in treating insomnia. As the number of herbs in the basic components group decreased, mean value in effectiveness of treatment also decreased consequentially. However, there were no statistical significances.

• The Journal of Korean Obstetrics and Gynecology
• /
• v.31 no.3
• /
• pp.1-19
• /
• 2018

Objectives: The purpose of this study was to analyze the research trends of randomized controlled trials on Traditional Korean Medicine treatment for postpartum depression in women. Methods: In order to investigate the effect of Traditional Korean Medicine on postpartum depression, randomized controlled trials on postpartum depression were searched using domestic and foreign search engines and a total of 11 studies were selected. Results: 1. There were 6 studies comparing Traditional Korean Medicine treatment methods with western medicine: fluoxetine hydrochloride (4), paroxetine (1), and mirazapine (1). 2. There were 5 studies comparing methods of Traditional Korean Medicine or sham acupuncture: 1 study evaluated the efficacy of Balance Acupuncture and Guipi Decoction, 1 study compared the effects of conventional acupuncture and Dispersing Liver Regulating Spirit Acupuncture, 1 study evaluated the efficacy of acupuncture and Heat-sensitive Moxibustion, 1 study compared the effects of conventional acupuncture and Musical Electroacupuncture, and 1 study compared the effects of conventional acupuncture and non-invasive sham acupuncture. 3. Postpartum depression is closely related to Heart and Liver, and there were many studies using acupoints Taichong (LR3) and Shenmen (HE7). Cranial acupoints Baihui (DU20) and Yintang (EX-HN3) were also frequently used. 4. Xiaoyaosan and Guipi Decoction were used in herbal medicine treatment for postpartum depression. 5. Novel treatment methods such as Heat-sensitive Moxibustion and Musical Electroacupuncture were used to treat postpartum depression. Conclusion: Traditional Korean Medicine treatment is a good treatment option for postpartum depression. Further systematic studies are needed to establish the basis for Traditional Korean Medicine treatment for postpartum depression.

• The Journal of Korean Medicine
• /
• v.44 no.3
• /
• pp.201-224
• /
• 2023

Objectives: The purpose of this study was to evaluate the effect of Gwibi-tang (GBT) on renal anemia. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to investigate changes in anemia levels before and after oral administration of GBT in patients with renal anemia. Relevant literature published up to May 25, 2023, was searched in 10 academic electronic databases. Results: Data from 489 patients from 7 RCTs were obtained and analyzed. All participants were receiving erythropoietin-stimulating agent treatment, and most of them were under hemodialysis. Additional administration of GBT to the participants significantly increased the hemoglobin concentration (10.55 g/L, 95% CI 6.99 to 14.11) compared to the control group. Hematocrit, red blood cell count, serum ferritin concentration, transferrin saturation, and the total effective rate for anemia was also significantly higher in the GBT-treated group than in the control group. Conclusions: This study suggests that GBT may be considered to be a promising option for the effective management of patients with renal anemia under conventional treatment. However, the limitations of this study, including the quantitative and qualitative weakness of the RCTs, the lack of safety-related evidence, and the absence of long-term follow-up data, should be taken into account when interpreting the results of this study.